Total Revenue
Labcorp Holdings Total Revenue increased by 0.6% to $3.54B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.8%, from $3.35B to $3.54B. Over 4 years (FY 2021 to FY 2025), Total Revenue shows relatively stable performance with a 1.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates market expansion or higher demand, while a decrease may signal market saturation or competitive pressure.
Detailed definition
Total revenue represents the gross inflow of economic benefits arising from the ordinary operating activities of the com...
Peer comparison
Standard across all public companies; peers in the medical device and diagnostics sector typically show steady growth correlated with product adoption.
total_revenueHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.84B | $4.06B | $1.07B | $3.90B | $2.92B | $2.87B | $2.93B | $3.04B | $3.03B | $3.06B | $3.03B | $3.18B | $3.22B | $3.28B | $3.33B | $3.35B | $3.53B | $3.56B | $3.52B | $3.54B |
| QoQ Change | — | +5.8% | -73.6% | +264.0% | -25.0% | -1.9% | +2.2% | +3.7% | -0.1% | +0.8% | -0.8% | +4.7% | +1.4% | +1.9% | +1.4% | +0.5% | +5.4% | +1.0% | -1.3% | +0.6% |
| YoY Change | — | — | — | — | -23.9% | -29.4% | +173.5% | -22.1% | +3.8% | +6.6% | +3.5% | +4.6% | +6.2% | +7.4% | +9.8% | +5.3% | +9.5% | +8.6% | +5.6% | +5.8% |
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Diagnostics | $2.52B | $2.55B | $2.59B | $2.63B | $2.75B | $2.77B | $2.73B | $2.76B |
| Biopharma Laboratory Services | — | — | — | $721.30M | $784.80M | $799.10M | $793.00M | $780.60M |
| Covance Drug Development | $707.00M | $737.70M | — | — | — | — | — | — |
| Drug Development | $707.00M | $737.70M | — | — | — | — | — | — |
| Total | $3.22B | $3.28B | $3.33B | $3.35B | $3.53B | $3.56B | $3.52B | $3.54B |
Covance Drug Development, Drug Development were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.
Total Revenue at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's total revenue?
- Labcorp Holdings (LH) reported total revenue of $3.54B in Q1 2026.
- How has Labcorp Holdings's total revenue changed year-over-year?
- Labcorp Holdings's total revenue increased by 5.8% year-over-year, from $3.35B to $3.54B.
- What is the long-term trend for Labcorp Holdings's total revenue?
- Over 4 years (2021 to 2025), Labcorp Holdings's total revenue has grown at a 1.5% compound annual growth rate (CAGR), from $13.14B to $13.95B.
- What does total revenue mean?
- The total amount of money a company brings in from its primary business activities before any expenses.